Clinical Trial Update: A Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary Incontinence [Phase 2]

View source ↗

Summary

A Phase 2a trial evaluating VMB-100 for stress urinary incontinence in females has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• VMB-100

Snippet

Sponsor: Versameb AG | Conditions: Stress Urinary Incontinence | Phase 2 | Status: WITHDRAWN